The "Molecular Diagnostics Patent Landscape Report" report has been added to ResearchAndMarkets.com's offering. The global ...

ABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to ...

In the United States, MDS cases are reported at a rate of 4.8 per 100,000 people annually, highlighting the pressing need for effective treatment solutions. As life expectancy increases globally, the ...

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take ...

SEKISUI Diagnostics launches Metrix COVID/Flu Test for use at the point-of-care and home: Burlington, Massachusetts Thursday, April 3, 2025, 17:00 Hrs [IST] SEKISUI Diagnostics, a ...

The veterinary diagnostics market is projected to grow from USD 4.04 billion in 2022 to USD 7.27 billion by 2030, driven by the increasing prevalence of zoonotic diseases and the rising adoption of ...

Molecular diagnosis of HAV along with anti-HAV IgG avidity measurement are helpful in case of positive IgM where laboratory evidence of acute hepatitis is absent and there is no epidemiologic link ...

ABL Diagnostics (FR001400AHX6 – ABLD, the“Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce an exclusive distribution agreement with Genient Tech Private Ltd. ( ).

NEW YORK — ABL Diagnostics said on Wednesday that it has signed an agreement for the distribution of its infectious disease molecular assays in India with Genient Tech Private.